Company Filing History:
1 out of 37 
1 out of 1 Years Active: 1993
Title: Ulla Mandel-Clausen: Innovator in Monoclonal Antibody Research
Introduction
Ulla Mandel-Clausen is a notable inventor based in Seattle, Washington. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has implications for contraception and the treatment of infertility in human females.
Latest Patents
Ulla Mandel-Clausen holds a patent for the monoclonal antibody NUH2. This antibody is capable of inactivating the motility of human sperm. The patent describes the production of monoclonal antibody NUH2 by a hybridoma with ATCC deposit number HB 9762. Additionally, it details an isolated antigen that specifically binds to anti-human sperm antibodies, including NUH2, which comprises at least an epitope with a sialyl I structure. The patent also covers methods for using the monoclonal antibody and antigen for contraception and treating infertility.
Career Highlights
Throughout her career, Ulla has worked with prominent organizations such as the Biomembrane Institute and Hyogo Medical College. Her research has been pivotal in advancing our understanding of reproductive health.
Collaborations
Ulla has collaborated with notable colleagues, including Edward D. Nudelman and Tokio Kaizu. Their combined expertise has contributed to the success of her research endeavors.
Conclusion
Ulla Mandel-Clausen's innovative work in monoclonal antibody research has the potential to impact reproductive health significantly. Her contributions continue to inspire advancements in biotechnology and medicine.